INCREASED NITRIC-OXIDE PRODUCTION IN PATIENTS WITH HYPOTENSION DURING HEMODIALYSIS

被引:110
作者
YOKOKAWA, K [1 ]
MANKUS, R [1 ]
SAKLAYEN, MG [1 ]
KOHNO, M [1 ]
YASUNARI, K [1 ]
MINAMI, M [1 ]
KANO, H [1 ]
HORIO, T [1 ]
TAKEDA, T [1 ]
MANDEL, AK [1 ]
机构
[1] WRIGHT STATE UNIV, DAYTON, OH 45435 USA
关键词
D O I
10.7326/0003-4819-123-1-199507010-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the involvement of nitric oxide production in hemodialysis-induced hypotension. Design: Examination of nitric oxide synthesis, cyclic guanosine 3'5'-monophosphate (cGMP) levels, and endothelin-1 levels in plasma before and after hemodialysis. Setting: Veterans Affairs medical center. Patients: 13 patients with end-stage renal failure who were receiving hemodialysis: Six patients had hypotensive episodes during dialysis and 7 did not. Intervention: Patients received heparin at a bolus dose of 2000 U at the initiation of dialysis followed by 1000 U/h during 4-hour hemodialysis sessions. Results: Nitric oxide production markedly increased during hemodialysis-induced hypotensive episodes; this increase was not seen in patients who did not have a hypotensive episode. In both groups, the plasma cGMP and endothelin-1 levels decreased after hemodialysis. According to multiple regression analysis, standard coefficients of nitric oxide production, plasma cGMP levels, and endothelin-1 levels with mean blood pressure after hemodialysis were -0.743, -0.07, and 0.31, respectively. Conclusion: Nitric oxide production increased in patients who had a hypotensive episode during hemodialysis but did not increase in those who did not have a hypotensive episode.
引用
收藏
页码:35 / 37
页数:3
相关论文
共 12 条
[1]  
ABBOTT EC, 1966, CAN MED ASSOC J, V94, P1155
[2]  
BEASLEY D, 1992, KIDNEY INT, V42, pS96
[3]   RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
BOULANGER, C ;
LUSCHER, TF .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :587-590
[4]   PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST [J].
CLOZEL, M ;
BREU, V ;
BURRI, K ;
CASSAL, JM ;
FISCHLI, W ;
GRAY, GA ;
HIRTH, G ;
LOFFLER, BM ;
MULLER, M ;
NEIDHART, W ;
RAMUZ, H .
NATURE, 1993, 365 (6448) :759-761
[5]   PARADOXICAL WITHDRAWAL OF REFLEX VASOCONSTRICTION AS A CAUSE OF HEMODIALYSIS-INDUCED HYPOTENSION [J].
CONVERSE, RL ;
JACOBSEN, TN ;
JOST, CMT ;
TOTO, RD ;
GRAYBURN, PA ;
OBREGON, TM ;
FOUADTARAZI, F ;
VICTOR, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1657-1665
[6]   PLASMA-IMMUNOREACTIVE ENDOTHELIN IN ESSENTIAL-HYPERTENSION [J].
KOHNO, M ;
YASUNARI, K ;
MURAKAWA, KI ;
YOKOKAWA, K ;
HORIO, T ;
FUKUI, T ;
TAKEDA, T .
AMERICAN JOURNAL OF MEDICINE, 1990, 88 (06) :614-618
[7]  
KOYAMA H, 1989, LANCET, V1, P991
[8]   ATRIAL-NATRIURETIC-PEPTIDE AND CYCLIC 3'5'-GUANOSINE MONOPHOSPHATE AS INDICATORS OF FLUID VOLUME OVERLOAD IN CHILDREN WITH CHRONIC-RENAL-FAILURE [J].
LETTGEN, B ;
BALD, M ;
VALLEE, H ;
BONZEL, KE ;
RASCHER, W .
PEDIATRIC NEPHROLOGY, 1992, 6 (01) :60-64
[9]   ENHANCED NITRIC-OXIDE SYNTHESIS IN UREMIA - IMPLICATIONS FOR PLATELET DYSFUNCTION AND DIALYSIS HYPOTENSION [J].
NORIS, M ;
BENIGNI, A ;
BOCCARDO, P ;
AIELLO, S ;
GASPARI, F ;
TODESCHINI, M ;
FIGLIUZZI, M ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 44 (02) :445-450
[10]   NEURAL CONTROL MECHANISMS AND VASOVAGAL SYNCOPE [J].
REA, RF ;
THAMES, MD .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1993, 4 (05) :587-595